Varicella Outbreak Surveillance in Schools – Results from Participating Health Departments, 2012-2015

Monday, June 20, 2016: 10:55 AM
Tikahtnu A, Dena'ina Convention Center
Adriana Lopez , Centers for Disease Control and Prevention, Atlanta, GA
Bethany LeClair , Georgia Department of Public Health, Atlanta, GA
Vicki W Buttery , Minnesota Department of Health, St. Paul, MN
Brenda Thorne , Houston Department of Health and Human Services, Houston, TX
Jennifer B. Rosen , New York City Department of Health and Mental Hygiene, Long Island City, NY
Elizabeth Taggert , Philadelphia Department of Public Health, Philadelphia, PA
Sara Robinson , Maine Center for Disease Control and Prevention, Augusta, ME
Mychal Davis , Kansas Department of Health and Environment, Topeka, KS
Catherine A. Waters , Arkansas Department of Health, Little Rock, AR
Carrie A. Thomas , West Virginia Department of Health and Human Resources, Charleston, WV
Mona Marin , Centers for Disease Control and Prevention, Atlanta, GA
BACKGROUND:  In 2007 a routine second dose of varicella vaccine was recommended for children ≥4-6 years of age to better control varicella-zoster virus circulation and outbreaks especially among school-aged populations with high 1-dose coverage. Surveillance for varicella outbreaks was established to monitor 2-dose program impact.

METHODS: Through CDC’s Epidemiology Laboratory Capacity funding, health departments conducted active surveillance for varicella outbreaks in elementary, middle, and high schools during the academic years of 2012-2013, 2013-2014, and 2014-2015. Health departments were required to include at least 300 schools under surveillance. Outbreaks of varicella were defined as ≥5 cases in a school within at least one incubation period (21 days). Cases and outbreaks of varicella were reported to health departments by school nurses, healthcare providers, or laboratories; demographic, vaccination, and clinical data were collected. We conducted descriptive analyses to examine outbreaks by academic year and case characteristics.  

RESULTS:  Georgia, Houston, Maine, Minnesota, New York City, and Philadelphia participated all 3 school years, Puerto Rico and West Virginia participated during 2012-2013, and Arkansas and Kansas participated during 2014-2015. A total of 29 outbreaks (with 262 cases) were reported: 14 in 2012-2013 among 3751 schools under surveillance (0.4%), 1 in 2013-2014 among 2755 schools (0.04%), and 14 in 2014-2015 among 6026 schools (0.2%); p=0.6. No outbreaks were reported from Houston and Puerto Rico. Median size and duration of outbreaks did not significantly differ over time (p>0.2) and were 8 cases (range, 5-31 cases) and 31 days duration (range, 4-100 days), respectively. Among case-patients associated with the 13 larger outbreaks, defined as being greater than or equal to the median outbreak size (i.e. ≥8 cases), 55% were unvaccinated, 16% were 1-dose and 18% were 2-dose vaccine recipients. In contrast, 33% of case-patients in 16 outbreaks with 5-7 cases were unvaccinated, 17% were 1-dose and 41% were 2–dose vaccine recipients. Of 257 outbreak cases with data on age, 143 (56%) were 5-9 and 67 (26%) were 10-14 years of age. Data on number of lesions were available for 204 cases, of which 100 (49%) were mild (<50 lesions) and 80 (39%) were mild/moderate (50-249 lesions).

CONCLUSIONS: The majority of cases associated with outbreaks occurred in under-vaccinated children (unvaccinated and 1-dose vaccine recipients). Although outbreaks included cases among 2-dose vaccine recipients, those with a greater proportion of 2-dose vaccine recipients were smaller in size. Full implementation of the 2-dose program could lead to further control of varicella outbreaks.